EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,842 | -61.1% | 17,872 | -52.1% | 0.00% | – |
| Q2 2023 | $724,762 | +138.3% | 37,282 | +247.8% | 0.00% | – |
| Q1 2023 | $304,099 | -77.2% | 10,719 | -76.5% | 0.00% | – |
| Q4 2022 | $1,335,315 | +411.6% | 45,683 | +361.3% | 0.00% | – |
| Q3 2022 | $261,000 | -31.0% | 9,903 | +16.3% | 0.00% | – |
| Q2 2022 | $378,000 | -71.8% | 8,515 | -68.5% | 0.00% | – |
| Q1 2022 | $1,339,000 | -22.0% | 27,064 | -19.7% | 0.00% | – |
| Q4 2021 | $1,717,000 | +32.6% | 33,712 | +45.3% | 0.00% | – |
| Q3 2021 | $1,295,000 | +273.2% | 23,204 | +186.4% | 0.00% | – |
| Q2 2021 | $347,000 | -60.9% | 8,101 | -61.9% | 0.00% | – |
| Q1 2021 | $888,000 | +44300.0% | 21,279 | +42458.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | -98.8% | 50 | -98.6% | 0.00% | – |
| Q1 2020 | $160,000 | -53.2% | 3,479 | -38.7% | 0.00% | – |
| Q4 2019 | $342,000 | -77.1% | 5,678 | -78.5% | 0.00% | -100.0% |
| Q3 2019 | $1,495,000 | -35.9% | 26,438 | -36.9% | 0.00% | 0.0% |
| Q2 2019 | $2,334,000 | +1297.6% | 41,915 | +1167.5% | 0.00% | – |
| Q1 2019 | $167,000 | -94.9% | 3,307 | -95.9% | 0.00% | -100.0% |
| Q4 2018 | $3,271,000 | +298.9% | 81,192 | +586.6% | 0.00% | – |
| Q3 2018 | $820,000 | +2177.8% | 11,825 | +2368.7% | 0.00% | – |
| Q2 2018 | $36,000 | -98.6% | 479 | -99.0% | 0.00% | -100.0% |
| Q1 2018 | $2,528,000 | +356.3% | 47,980 | +362.1% | 0.00% | – |
| Q4 2017 | $554,000 | -66.3% | 10,383 | -62.3% | 0.00% | -100.0% |
| Q3 2017 | $1,644,000 | +52.6% | 27,569 | +101.9% | 0.00% | 0.0% |
| Q2 2017 | $1,077,000 | +870.3% | 13,655 | +921.3% | 0.00% | – |
| Q1 2017 | $111,000 | -92.9% | 1,337 | -93.2% | 0.00% | -100.0% |
| Q4 2016 | $1,562,000 | +78.3% | 19,684 | +57.3% | 0.00% | – |
| Q3 2016 | $876,000 | +26.6% | 12,515 | -29.8% | 0.00% | – |
| Q2 2016 | $692,000 | +88.0% | 17,822 | +95.9% | 0.00% | – |
| Q1 2016 | $368,000 | -86.7% | 9,096 | -70.8% | 0.00% | -100.0% |
| Q4 2015 | $2,758,000 | +437.6% | 31,105 | +349.0% | 0.00% | – |
| Q3 2015 | $513,000 | +12.0% | 6,928 | +22.1% | 0.00% | – |
| Q2 2015 | $458,000 | – | 5,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |